{"input_url":"https://finance.biggo.com/news/9b59ee88-2c43-4c79-bb3b-e834c982c36d","gnews_decode":"https://finance.biggo.com/news/9b59ee88-2c43-4c79-bb3b-e834c982c36d","http_status":200,"final_url":"https://finance.biggo.com/news/9b59ee88-2c43-4c79-bb3b-e834c982c36d","html_length":133057,"trafilatura_result":"ok","text_length":5318,"text_preview":"Hims & Hers Stock Jumps 13% After FDA Panel Backs BPC-157 for Compounding\nShares of Hims & Hers Health (HIMS) surged as much as 13% on Thursday, bucking a broad market decline, after a key Food and Drug Administration advisory panel voted to recommend adding the peptide BPC-157 to a list that would ","verdict":"OK"}